The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamata, T.
Right arrow Articles by Takada, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamata, T.
Right arrow Articles by Takada, Y.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2002, 168: 2296-2301.
Copyright © 2002 by The American Association of Immunologists

The Role of the CPNKEKEC Sequence in the {beta}2 Subunit I Domain in Regulation of Integrin {alpha}L{beta}2 (LFA-1)1

Tetsuji Kamata2,*, Kenneth Khiem Tieu*, Takehiko Tarui*, Wilma Puzon-McLaughlin*, Nancy Hogg{dagger} and Yoshikazu Takada2,*

* Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037; and {dagger} Leukocyte Adhesion Laboratory, Imperial Cancer Research Fund, London, United Kingdom

The {alpha}L I (inserted or interactive) domain of integrin {alpha}L{beta}2 undergoes conformational changes upon activation. Recent studies show that the isolated, activated {alpha}L I domain is sufficient for strong ligand binding, suggesting the {beta}2 subunit to be only indirectly involved. It has been unclear whether the activity of the {alpha}L I domain is regulated by the {beta}2 subunit. In this study, we demonstrate that swapping the disulfide-linked CPNKEKEC sequence (residues 169–176) in the {beta}2 I domain with a corresponding {beta}3 sequence, or mutating Lys174 to Thr, constitutively activates {alpha}L{beta}2 binding to ICAM-1. These mutants do not require Mn2+ for ICAM-1 binding and are insensitive to the inhibitory effect of Ca2+. We have also localized a component of the mAb 24 epitope (a reporter of {beta}2 integrin activation) in the CPNKEKEC sequence. Glu173 and Glu175 of the {beta}2 I domain are identified as critical for mAb 24 binding. Because the epitope is highly expressed upon {beta}2 integrin activation, it is likely that the CPNKEKEC sequence is exposed or undergoes conformational changes upon activation. Deletion of the {alpha}L I domain did not eliminate the mAb 24 epitope. This confirms that the {alpha}L I domain is not critical for mAb 24 binding, and indicates that mAb 24 detects a change expressed in part in the {beta}2 subunit I domain. These results suggest that the CPNKEKEC sequence of the {beta}2 I domain is involved in regulating the {alpha}L I domain.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Shimaoka, M. Kim, E. H. Cohen, W. Yang, N. Astrof, D. Peer, A. Salas, A. Ferrand, and T. A. Springer
AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes
PNAS, September 19, 2006; 103(38): 13991 - 13996.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Chen, W. Yang, M. Kim, C. V. Carman, and T. A. Springer
Regulation of outside-in signaling and affinity by the beta2 I domain of integrin {alpha}Lbeta2
PNAS, August 29, 2006; 103(35): 13062 - 13067.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. J. Evans, A. McDowall, P. C. Taylor, N. Hogg, D. O. Haskard, and R. C. Landis
Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory response
Blood, May 1, 2006; 107(9): 3593 - 3599.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Salas, M. Shimaoka, U. Phan, M. Kim, and T. A. Springer
Transition from Rolling to Firm Adhesion Can Be Mimicked by Extension of Integrin {alpha}Lbeta2 in an Intermediate Affinity State
J. Biol. Chem., April 21, 2006; 281(16): 10876 - 10882.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Chen, C.-X. Sun, and J.-N. Liu
A Novel Anti-platelet Monoclonal Antibody (3C7) Specific for the Complex of Integrin {alpha}IIb{beta}3 Inhibits Platelet Aggregation and Adhesion
J. Biol. Chem., July 8, 2005; 280(27): 25403 - 25408.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kamata, M. Handa, Y. Sato, Y. Ikeda, and S. Aiso
Membrane-proximal {alpha}/{beta} Stalk Interactions Differentially Regulate Integrin Activation
J. Biol. Chem., July 1, 2005; 280(26): 24775 - 24783.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Anikeeva, K. Somersalo, T. N. Sims, V. K. Thomas, M. L. Dustin, and Y. Sykulev
Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes
PNAS, May 3, 2005; 102(18): 6437 - 6442.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Bouaouina, E. Blouin, L. Halbwachs-Mecarelli, P. Lesavre, and P. Rieu
TNF-Induced {beta}2 Integrin Activation Involves Src Kinases and a Redox-Regulated Activation of p38 MAPK
J. Immunol., July 15, 2004; 173(2): 1313 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Yang, M. Shimaoka, A. Salas, J. Takagi, and T. A. Springer
Intersubunit signal transmission in integrins by a receptor-like interaction with a pull spring
PNAS, March 2, 2004; 101(9): 2906 - 2911.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. Yang, M. Shimaoka, J. Chen, and T. A. Springer
Activation of integrin {beta}-subunit I-like domains by one-turn C-terminal {alpha}-helix deletions
PNAS, February 24, 2004; 101(8): 2333 - 2338.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Mould, S. J. Barton, J. A. Askari, S. E. Craig, and M. J. Humphries
Role of ADMIDAS Cation-binding Site in Ligand Recognition by Integrin {alpha}5{beta}1
J. Biol. Chem., December 19, 2003; 278(51): 51622 - 51629.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Tsuruta, S. B. Hopkinson, K. D. Lane, M. E. Werner, V. L. Cryns, and J. C. R. Jones
Crucial Role of the Specificity-determining Loop of the Integrin {beta}4 Subunit in the Binding of Cells to Laminin-5 and Outside-in Signal Transduction
J. Biol. Chem., October 3, 2003; 278(40): 38707 - 38714.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. D. Evans, V. C. Perkins, A. Henry, P. E. Stephens, M. K. Robinson, and F. M. Watt
A tumor-associated {beta}1 integrin mutation that abrogates epithelial differentiation control
J. Cell Biol., February 18, 2003; 160(4): 589 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Xia, G. Borland, J. Huang, I. F. Mizukami, H. R. Petty, R. F. Todd III, and G. D. Ross
Function of the Lectin Domain of Mac-1/Complement Receptor Type 3 (CD11b/CD18) in Regulating Neutrophil Adhesion
J. Immunol., December 1, 2002; 169(11): 6417 - 6426.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.